Panion Animal Health AB (Publ):First trading day for series 2019 warrants

Panion Animal Health AB today announced that the first trading day of warrants of series 2019 will be July 12, 2018. One (1) warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 1.31 per share. Subscription of shares under the warrants shall be in accordance with the terms of the warrants during the period from September 1, 2019 through September 30, 2019.

Shares and share capital 
The preferential share issue of units has been partly registered at the Swedish Companies Registration Office and the total number of shares amounts to 20 748 042 giving a share capital of SEK 966 939,224775.

Name: Panion Animal Health AB TO 2019
Short name: PANION TO 2
ISIN: SE0011205343 
First day of trading: 12 July 2018 
Last day of trading: 26 September 2019 Outstanding warrants of series 2019: 4 531 312

Anja E. H. Holm, CEO
+ 45-22 94 66 00
anja.holm@panion-animalhealth.com

Bolaget ska utveckla och kommersialisera genterapi för behandling av epilepsiliknande tillstånd hos hundar och andra djur, samt utveckla och kommersialisera andra veterinärmedicinska produkter och nya behandlingsformer som kan ge sjuka djur bättre livskvalitet.
Panion will develop and commercialize a gene therapy treatment for dogs with drug refractory epilepsy, and other new animal health products and treatments that improve the quality of life for animals suffering from chronic diseases.

Nerladdningsbara filer

2018 Q3 report, Period July-September for Panion Animal Health AB

Period July-September

  • Net sales: kSEK 0 (0).
  • Operating profit: kSEK -536 (-923).
  • Earnings per share: SEK -0,03 (-0,25).
  • Liquidity at the end of the period: kSEK 1 987 (1 166).

Period January-September

  • Net sales: kSEK 0 (0).
  • Operating profit: kSEK -2 532 (-3 501).
  • Earnings per share: SEK -0,03 (-0,25).
  • Liquidity at the end of the period: kSEK 1 987 (1 166).


New CFO in Panion; Katarina Holm

The new CFO for Panion Animal Health AB from the 1.st of November 2018 is Katarina Holm, who cooperates with our current CFO, Sofia Josephson, for a smooth transition of the role.


Panion prepares for USA







2018 Q2 report, Period April-June for Panion Animal Health AB

Period April-June

  • Net sales: kSEK 0 (0). 
  • Operating profit: kSEK -1 299 (-1 156). 
  • Earnings per share: SEK -0,08 (-0,21). 
  • Liquidity at the end of the period: kSEK 15 (796).

Period January-June

  • Net sales: kSEK 0 (0). 
  • Operating profit: kSEK -1 996 (-2 423). 
  • Earnings per share: SEK -0,08 (-0,21). 
  • Liquidity at the end of the period: kSEK 15 (796).

Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Sturegatan 32
114 36 Stockholm

08-692 21 90
Kontaktformulär

Kontakta oss

Vill du veta mer om beQuoted och våra tjänster så fyll i nedanstånde uppgifter och tryck skicka.

En av våra rådgivare kontaktar dig inom kort.

Namn: Telefon: E-postadress: Meddelande: